THERE IS AN OPINION… |
|
Nikolaev N.A.
Should the application of clinical guidelines be mandatory or recommendatory?
|
7-13 |
ORIGINAL STUDIES |
|
Rebrov A.P., Tyapkina M.A., Ordyakova A.A., Yupatov V.D., Kosheleva N.A., Basov I.V.
Patients with cardiovascular diseases and NSAIDs intake: Is there a real problem today?
|
14-21 |
|
Tkachenko V.V., Tuev A.V., Karpunina N.S., Shishkina E.A.
Myocardial infarction in young men: androgen levels and predictors of post-hospital adverse cardiovascular events
|
22-29 |
|
Shushanova A.S., Gladkikh N.N., Yagoda A.V.
Myocardial infarction type 1 at young age: Contribution of proatherogenic factors and genetic thrombophilies
|
30-37 |
|
Davydova A.V., Nikiforov V.S., Khalimov Yu.Sh.
The role of adipokines and epicardial fat tissue thickness in prognostication of acute coronary syndrome outcomes
|
38-46 |
|
Pyrikova N.V., Mozgunov N.A., Osipov I.V.
Results of a 12-month telemonitoring of chronic heart failure patients after hospitalization with its decompensation
|
48-57 |
REVIEWS |
|
Bolieva L.Z., Adasheva T.V., Daurova M.D.
Coxibs cardiovascular safety
|
58-65 |
|
Adasheva T.V., Samorukova E.I., Gubernatorova E.E., Lobanova E.G., Shahrai N.B.
Anticoagulant therapy for non-valvular atrial fibrillation patients with CHA2DS2-VASC score 1 (regardless of gender): A personalized approach based on risk/benefit analysis
|
66-76 |
|
Boeva O.I., Kokorin V.A., Latiy V.V.
Lipid-lowering therapy today and tomorrow
|
77-87 |
GUIDELINES FOR PRACTITIONERS |
|
Klyagina K.I., Adasheva T.V., Mershina E.A., Goruleva E.I., Semochkin S.V., Chernysheva O.O., Shakhrai N.B.
A clinical case of amyloid cardiomyopathy in association of t-cell leukemia
|
88-97 |
|
Ponomareva E.Yu., Sedov D.S.
Left-sided infectious endocarditis in a patient receiving program hemodialysis treatment
|
98-102 |
|
Roitberg G.E., Ardashev A.V., Zhelyakov E.G., Kondratova N.V., Merzyavko L.K., Ponkina N.K., Slastnikova I.D., Sokolov D.V.
Modern opportunities for treatment of patient having chronic heart failure with low ejection fraction
|
103-111 |
|
Kornilova L.E., Sokov E.L., Dlin S.V., Urazov V.V., Kornilova A.A., Artamonov M.Yu., Sokov P.E.
Bone transcortical capillary vessels grid network infusion usage in the neuropathic pain treatment in diabetic distal symmetrical polyneuropathy
|
112-118 |
LECTURES & REPORTS |
|
Stuklov N.I., Gurkina A.A., Kovalchuk M.S., Kisly N.D.
Modern concepts concerning the mechanisms of iron absorption: activators, inhibitors, regulation, new possibilities of optimization
|
119-129 |
Guideline for practitioners |
|
Avdeev S.N., Bashankaev B.N., Briko N.I., Gorelov A.V., Zhdanov K.V., Kozlov R.S., Malyavin A.G., Martynov A.I., Polibin R.V., Sinopalnikov A.I., Tkacheva O.N., Fedenko A.A.
Resolution of RSMSIM Expert council «State and prospects of pneumococcal vaccination in the Russian Federation»
|
130-136 |
|
Shishkova V.N.
Special features of the psycho-emotional state of comorbid patients in therapist’s practice: what is important to take into consideration in their curation tactics
|
137-144 |
|
Malimon V.V., Kokorin V.A.
New opportunities for chronic heart failure patients’ treatment: Focus at dapagliflosin
|
145-152 |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
|
Statsenko M.E., Turkina S.V., Lopushkova Yu.E.
The effect of meldonium on the heart rate variability in the complex therapy of patients with chronic heart failure and chronic obstructive pulmonary disease
|
153-161 |
|
Syrov A.V.
Indapamide in the treatment of arterial hypertension
|
162-172 |
|
Mubarakshina O.A., Batishcheva G.A., Dronova Yu.M.
Treatment and prevention of functional constipation using drinking medical mineral water
|
173-179 |
Activities of RNMOT |
|
Digest of interregional scientific and practical events under the aegis or with the participation of RSMSIM (April-May 2023)
|
180-186 |
Русский
